Accepted at 6:56 p.m. Oct, 31, 2023 by dollajas
Author: crazily_engraver360
Related Note: 1463875484080
Rationale for change

Sorry but why was the answer written like that? Lol

Text Text
Extra
Lecture Notes
Empty field
Missed Questions
Empty field
Pathoma
Empty field
Boards and Beyond
Empty field
First Aid
Sketchy
Sketchy 2
Empty field
Sketchy Extra
Empty field
Picmonic
Empty field
Pixorize
Empty field
Physeo
Empty field
Bootcamp
OME
Additional Resources
Empty field
One by one
Empty field
#AK_Step1_v12::#Bootcamp::Pharmacology::01_Pharmacodynamics::08_Receptor_Physiology #AK_Step1_v12::#OME::04_Organ_Systems::06_Endocrine::01_Pituitary::02_The_Unhealthy_Anterior_Pituitary #AK_Step1_v12::#UWorld::Step::1720 #AK_Step1_v12::#Low/HighYield::1-HighYield #AK_Step1_v12::^Systems::Endocrine::Pharmacology #AK_Step1_v12::#FirstAid::08_Endocrine::05_Pharm::04_Hypothalamic/pituitary_drugs::*Growth_Hormone_Physiology #AK_Step1_v12::#SketchyPharm::05_GI_&_Endocrine::04_Hypothalamic_&_Pituitary::01_Growth_hormone,_mecasermin,_octreotide,_pegvisomant #AK_Other::#AK_Original_Decks::Step_1::Zanki_Pharmacology #AK_Step1_v12::#OME::PreClinical::04_Organ_Systems::06_Endocrine::01_Pituitary::02_The_Unhealthy_Anterior_Pituitary #AK_Step1_v12::#B&B::09_Endocrinology::05_Other::06_Signaling_Pathways #AK_Step1_v12::#UWorld::COMLEX::24831